Infection Medicine

2019 News

News in 2019 from Infection Medicine

EASTBIO PhD projects available at Infection Medicine

A number of BBSRC EASTBIO PhD projects are currently available at Infection Medicine.

Prof Till Bachmann launches AMR Teaching and Training survey

We would like to invite you join a 15 min survey about teaching & training for AMR diagnostics.

Sloan Lab publish in Journal of Virology

The Sloan Lab of Infection Medicine have published a paper in collaboration with Professor Áine McKnight (Barts and The London School of Medicine) showing how HIV uses its Vpr countermeasure protein to overcome the host antiviral factor REAF/RPRD2 and aid infection.

PhD in Precision Medicine position in Sloan Lab

Precision Medicine Project - How do IFITM proteins regulate the Interferon Related DNA-damage Resistance Signature (IRDS) and clinical outcomes in cancers of high unmet clinical need?

PhD in Precision Medicine position available at Michlewski lab

Precision Medicine Project - Comprehensive study of miRNAs biogenesis in human cancer

Postdoctoral Fellowships for Edinburgh-Zhejiang projects in Michlewski and Sloan labs

Opportunity for Postdoctoral Fellowship – Edinburgh University - Zhejiang University partnership

PhD posts available in Antimicrobial Resistance and Antiviral Innate Immunity

Edinburgh-Leiden Integrated One Health Solutions 4 year PhD posts are currently available in the Schneiders Lab and in the Sloan Lab at Infection Medicine - closing date 15th November

Introduction of new rapid tests essential to reducing unnecessary antibiotic use

Cross-sector roundtable event held to mark launch of landmark new exhibition 'Superbugs: The End of Antibiotics?’

Dr Gracjan Michlewski awarded new BBSRC grant

Dr Gracjan Michlewski has been awarded a grant worth £510,000 to investigate the role of novel RNA-binding protein TRIM25 in viral nucleic acids sensing and signalling.

New paper by Michlewski lab in Nature Communications

Dr Gracjan Michlewski, Principal Investigator at Infection Medicine, published a new paper in Nature Communications.

Dr Till Bachmann is a member of Value Dx

University of Antwerp, bioMérieux, and Wellcome Trust to coordinate VALUE-Dx, a European Public-Private Partnership to fight antimicrobial resistance through diagnostics.

Infection Medicine Promotion

The Division congratulates Professor Till Bachmann for his achievements.

Principal formally opens China medical campus

Edinburgh Principal Professor Peter Mathieson has officially opened a campus in China that will translate medical research into technologies to improve healthcare.

Michlewski Lab publish a collaborative paper in Molecular Cell

An international group of researchers led by Dr Alfredo Castello (University of Oxford) developed ‘comparative RNA-interactome capture’ to analyse the RNA-bound proteome during virus infection. >200 cellular RNA-binding proteins change their binding activity in response to this challenge, mainly driven by transcript availability. Many of these RNA-binding proteins regulate viral replication and can be targeted to influence infection outcome.

Edinburgh researchers showcase AMR research in the UK parliament

A group of academics from the University of Edinburgh has taken part in a Q&A highlighting how research is tacking the challenge of AMR in the UK parliament.

Sloan lab publish paper in the Proceedings of the National Academy of Sciences of the United States of America (PNAS)

Working in collaboration with Professor Linrong Lu, Zhejiang University China, this study has arisen directly as a result of the ongoing teaching and research collaboration between the School of Biomedical Sciences, University of Edinburgh and Zhejiang University China. It identifies a key role for the phosphatase PP2A in regulating levels of inflammatory TH17 cells and shows a novel therapeutic strategy to control certain autoimmune diseases may be achieved through small molecule inhibition of PP2A.